The Institute for Clinical and Economic Review (ICER) announced Tuesday it will work with the Department of Veterans Affairs (VA) Pharmacy Benefits Management Services (PBM) office in drug coverage and price negotiations with pharmaceutical companies.
ICER, according to a press release, will incorporate previous drug assessment reports to help bolster the partnership’s efforts.
“As part of this arrangement, ICER will work with staff in the VA PBM to facilitate their integration of ICER reports into the VA formulary management process of evaluating the comparative clinical effectiveness and value of drugs,” ICER said in the release.
As part of the partnership, ICER and the VA staff will develop “value-based price benchmarks” recommended in ICER reports to ensure “excellent” access to vital treatments and efficient use of VA resources.
“Our mission has always been to support a more effective, affordable and just health care system by providing objective analysis of the effectiveness and value of different care options,” ICER President Dr. Steven Pearson said. “We are therefore very proud to begin a concerted effort to work with, and learn from, the pharmacy team at the VA.”